Oculis Holding AG
OCS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001953530
No open-market purchases or sales by Oculis Holding AG insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $322.0M in total; no superinvestor holds it.
Other share classesOCSAW
13F holders, Q4 2025
Institutional positions in Oculis Holding AG as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +21 vs. Q3 2025
- Shares held
- 18.1M
- +7.18M (+65.9%) vs. Q3 2025
- Total value
- $363.8M
- +$172.1M (+89.7%) vs. Q3 2025
- New holders
- 22
- 9 more added
- Sold out
- 1
- 4 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OCS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $322.0M |
| Q1 2026 | 57 | $534.7M |
| Q4 2025 | 41 | $363.8M |
| Q3 2025 | 20 | $191.7M |
| Q2 2025 | 23 | $99.1M |
| Q1 2025 | 20 | $94.7M |
| Q4 2024 | 12 | $59.4M |
| Q3 2024 | 10 | $36.9M |
| Q2 2024 | 11 | $39.8M |
| Q1 2024 | 9 | $40.9M |
| Q4 2023 | 7 | $44.3M |
| Q3 2023 | 9 | $32.1M |
| Q2 2023 | 9 | $38.5M |
| Q1 2023 | 7 | $23.2M |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Oculis Holding AG; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SBI Securities Co., Ltd. | 1 | $20 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1 | $20 | 0.00% | +1 | New |
| DuPont Capital Management Corp | 4 | $80 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 210 | $4.19K | 0.00% | +210 | New |
| China Universal Asset Management Co., Ltd. | 2,000 | $39.9K | 0.00% | +1,000+100.0% | Added |
| Morgan Stanley | 3,050 | $60.9K | 0.00% | −3,366−52.5% | Reduced |
| JPMorgan Chase & Co | 3,180 | $63.5K | 0.00% | +3,180 | New |
| BNP Paribas Arbitrage, SA | 3,600 | $71.9K | 0.00% | +3,600 | New |
| Aventura Private Wealth, LLC | 4,000 | $79.9K | 0.03% | 00.0% | Unchanged |
| State Street Corp | 12,519 | $250.0K | 0.00% | +140+1.1% | Added |
| Gsa Capital Partners LLP | 13,042 | $260.0K | 0.02% | +13,042 | New |
| Millennium Management LLC | 15,641 | $312.4K | 0.00% | +15,641 | New |
| Northern Trust Corp | 21,189 | $423.1K | 0.00% | −615−2.8% | Reduced |
| Two Sigma Investments, LP | 24,444 | $488.1K | 0.00% | +24,444 | New |
| Renaissance Technologies LLC | 25,000 | $499.3K | 0.00% | +25,000 | New |
| Geode Capital Management, LLC | 36,061 | $720.1K | 0.00% | +6,625+22.5% | Added |
| HRT Financial LP | 43,914 | $876.0K | 0.00% | +43,914 | New |
| Marshall Wace, LLP | 45,773 | $914.1K | 0.00% | +45,773 | New |
| UBS Group AG | 45,916 | $916.9K | 0.00% | −28,816−38.6% | Reduced |
| Alps Advisors Inc | 46,947 | $937.5K | 0.01% | +46,947 | New |
| Bank of America Corp | 63,951 | $1.28M | 0.00% | +25,416+66.0% | Added |
| Simplify Asset Management Inc. | 98,765 | $1.97M | 0.03% | +98,765 | New |
| Acuta Capital Partners, LLC | 101,777 | $2.03M | 1.38% | 00.0% | Unchanged |
| Compagnie Lombard Odier SCmA | 107,300 | $2.14M | 0.02% | +10,300+10.6% | Added |
| Neo Ivy Capital Management | 54,771 | $2.55M | 0.40% | +54,771 | New |
| NEXTBio Capital Management LP | 149,750 | $2.99M | 1.75% | +149,750 | New |
| Citadel Advisors LLC | 165,487 | $3.30M | 0.00% | +165,487 | New |
| Propel Bio Management, LLC | 172,839 | $3.45M | 2.95% | +172,839 | New |
| Folketrygdfondet | 182,800 | $3.65M | 0.08% | +182,800 | New |
| Syquant Capital SAS | 192,722 | $3.85M | 0.47% | +192,722 | New |
| Woodline Partners LP | 201,200 | $4.02M | 0.02% | +117,367+140.0% | Added |
| Alyeska Investment Group, L.P. | 331,332 | $6.62M | 0.02% | +200,000+152.3% | Added |
| Perceptive Advisors LLC | 493,827 | $9.86M | 0.18% | +493,827 | New |
| Nan Fung Group Holdings Ltd | 514,702 | $10.3M | 9.20% | 00.0% | Unchanged |
| Saturn V Capital Management LLC | 516,761 | $10.3M | 1.89% | +516,761 | New |
| Sr One Capital Management, LP | 641,022 | $12.8M | 1.81% | +318,522+98.8% | Added |
| Wellington Management Group LLP | 1,356,179 | $27.1M | 0.00% | +1,356,179 | New |
| Standard Life Aberdeen plc | 1,746,946 | $34.9M | 0.05% | +493,827+39.4% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 2,288,658 | $45.7M | 17.67% | −12,116−0.5% | Reduced |
| Gildi - lifeyrissjodur | 2,447,985 | $50.3M | 22.73% | +2,447,985 | New |
| EQT Fund Management S.a r.l. | 5,900,294 | $117.8M | 10.60% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 0 | $0 | 0.00% | −269−100.0% | Sold out |